Rockwell Medical Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -7.1% | +2.6% | +13.9% | +9.6% | -12.9% | -23.3% | -15.0% | -0.9% | +15.2% | -5.5% | +2.6% | – | |
| – | -10.9% | +2.0% | +8.5% | +3.7% | -4.7% | -24.5% | -14.5% | +0.6% | +6.0% | -0.2% | +0.7% | – | |
| – | +30.3% | +6.8% | +48.5% | +37.1% | -41.8% | -16.2% | -17.7% | -9.2% | +70.7% | -25.3% | +11.9% | – | |
| – | -66.0% | -89.3% | -100.0% | – | – | -100.0% | – | – | – | – | – | – | |
| – | -6.3% | +39.4% | -8.7% | +3.7% | -7.6% | +11.6% | -11.1% | +1.4% | +12.4% | +2.0% | -3.2% | – | |
| – | -13.3% | +28.4% | -8.0% | +6.6% | -3.6% | +6.1% | -12.5% | +0.1% | +10.9% | +2.4% | -1.7% | – | |
| – | – | – | – | +275.9% | -126.8% | – | – | – | – | – | – | – | |
| – | +169.6% | -61.1% | -46.2% | +30.2% | -4.3% | -4.2% | -0.4% | +3.3% | +0.4% | -1.4% | -0.4% | – | |
| – | – | – | – | +385.1% | -145.4% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +385.1% | -145.4% | – | – | – | – | – | – | – | |
| – | – | -617.1% | – | +123.2% | -97.0% | -1,019.7% | – | – | – | -392.1% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.